
Journal of Pharmaceutical Sciences p. 887 - 894 (1983)
Update date:2022-08-05
Topics:
Dimmock
Shyam
Hamon
Logan
Raghavan
Harwood
Smith
Series of 3-dimethylamino-1-aryl-1-propanone hydrobromides (IV) and 3-dimethylamino-2-dimethylaminomethyl-1-aryl-1-propanone dihydrobromides (V) were synthesized. Evaluation of these derivatives against P-388 lymphocytic leukemia growth revealed that two compounds show promise as antineoplastic agents. Compounds of the V series were unstable in phosphate buffer (in contrast to series IV), and when the same nuclear substituent was present in both series of compounds, V was ~ 100 times more active than IV in both the stimulation and inhibition of respiration of mitochondria isolated from rat liver cells. Representatives from both series showed that respiration in mitochondria was affected by changing the pH of the aqueous buffer from 7.4 to 6.9 or 6.4 and by reducing the temperature from 37° to 20°. The compounds showed reactivity toward a biomimetic thiol.
View MoreShaanxi Hongkang Biological Technology Co., Ltd.
Contact:+8618834254612
Address:No.6 Gaoxin Road
Xuzhou Tianrun Chemical Co.,Ltd
website:http://www.tianrunchem.cn
Contact:86-516-83832636
Address:fuxing road
Shanghai Yuking Water Soluble Material Tech Co., Ltd
Contact:86-21-68286299
Address:4F, 13B, No. 600, South Xinyuan Road 201306, Shanghai, China
Nantong LiKai Chemical Co.,Ltd
Contact:+86-513-89068669
Address:Jincheng Science Park
Jiangxi Runhao Pharmaceutical Stock Co.,ltd.
Contact:86-791-8861 9931
Address:Industrial Area of Shuibian town,Xiajiang county,Ji'an city,Jiangxi Province.
Doi:10.1039/jr9490002337
(1949)Doi:10.1021/jo00189a027
(1984)Doi:10.1021/jo00190a002
(1984)Doi:10.1007/BF00757965
(1988)Doi:10.1055/s-0029-1218634
(2010)Doi:10.1021/om060016j
(2006)